Kir2.1 (KCNJ2) was overexpressed in 44.23% of small-cell lung cancer (SCLC) tissues and is correlated with the clinical stage and chemotherapy response in patients with SCLC [31]. The gene discussed is KCNJ2; the disease is small cell lung carcinoma.